MedTrace Logo

HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

NCT04389294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2024-01-03

Study results available
· View outcomes & findings →

Summary

The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.

Conditions

Interventions

DIAGNOSTIC_TEST

SARS-CoV2 serum antibody testing

Participants will have SARS-CoV2 serum antibody testing performed twice within 4 months of each other.

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2020-06-16
Completion
2020-09-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389294 on ClinicalTrials.gov